AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

BetterLife Pharma Inc.

CAD 0.36 +$0.32 (+700.00%)
CNQ · 14 Sep 2026 14:41 UTC
Previous Close
CAD 0.34
Day Range
CAD 0.34CAD 0.39
Year Range
CAD 0.04CAD 0.46
Market Cap
58.28M
AVG Volume
303.93K
Trailing/Forward PE
-28.8/-
PEG ratio
0.22
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Canadian Securities ExchangeCA
Revenue (CAD)
020K40K60K80K2017201820192020202120222023202420252026
BETR.CN Revenue (CAD) by year
PeriodRevenue (CAD)
20260
20250
20240
20230
20220
20210
202070.97K
20190
20180
20170
Net Income (CAD)
-40M-30M-20M-10M02017201820192020202120222023202420252026
BETR.CN Net Income (CAD) by year
PeriodNet Income (CAD)
2026-1.5M
2025-3.52M
2024-3.48M
2023-9.01M
2022-12.16M
2021-36.04M
2020-19.53M
2019-9.09M
2018-175.42K
2017-7.9M
Operating Income (CAD)
-20M-15M-10M-5M02017201820192020202120222023202420252026
BETR.CN Operating Income (CAD) by year
PeriodOperating Income (CAD)
2026-1.66M
2025-4.94M
2024-3.35M
2023-9.46M
2022-10.21M
2021-7.78M
2020-18.72M
2019-6.79M
2018-1.31M
2017-7.56M
EBITDA (CAD)
-40M-30M-20M-10M02017201820192020202120222023202420252026
BETR.CN EBITDA (CAD) by year
PeriodEBITDA (CAD)
2026-1.41M
2025-2.59M
2024-2.85M
2023-9.29M
2022-11.92M
2021-35.65M
2020-17.49M
2019-6.58M
2018-281.51K
2017-7.63M
Cash Flows (CAD)
-15M-10M-5M02017201820192020202120222023202420252026
BETR.CN Cash Flows (CAD) by year
PeriodCash Flows (CAD)
2026-625.46K
2025-2.02M
2024-2.47M
2023-1.5M
2022-11.2M
2021-7.26M
2020-7.99M
2019-4.98M
2018-488.06K
2017-495.06K
EPS (CAD)
-1.5-1-0.500.52017201820192020202120222023202420252026
BETR.CN EPS (CAD) by year
PeriodEPS (CAD)
2026-0.01
2025-0.03
2024-0.03
2023-0.11
2022-0.16
2021-0.84
2020-1.24
2019-1.02
20180.02
2017-1.05
Expenses (CAD)
-2.5M02.5M5M7.5M10MR&DSG&ACapex2017201820192020202120222023202420252026
BETR.CN Expenses (CAD) by year
PeriodExpenses (CAD)
20261.81M
20254.72M
20243.21M
20239.37M
20229.95M
20217.75M
20207.9M
20195.51M
20181.14M
20177.31M
Cash & Debt (CAD)
01M2M3M4MCashLong Term DebtShort Term Debt2017201820192020202120222023202420252026
BETR.CN Cash & Debt (CAD) by year
PeriodCash & Debt (CAD)
202612.57K
20258.18K
202437.38K
20238.31K
2022173.51K
2021154.72K
20202.68M
201974.8K
201879.59K
2017147.32K
Debt ratios
-0.15-0.1-0.05-020192020202120222023202420252026
BETR.CN Debt ratios by year
PeriodDebt ratios
2026-0.06
2025-0.05
2024-0
2023-0.02
2022-0.02
2021-0.01
2020-0.06
2019-0.13
Margins
-150%-100%-50%0%2020
BETR.CN Margins by year
PeriodMargins
2020-111.18%
Return on Capital
-1000%-500%0%500%1000%2017201820192020202120222023202420252026
BETR.CN Return on Capital by year
PeriodReturn on Capital
202623.06%
202547.82%
202445.23%
2023119.65%
2022313.31%
2021781.33%
2020-734.98%
2019-258.97%
2018313.31%
2017408.82%
Shares Outstanding
050M100M150M200M2017201820192020202120222023202420252026
BETR.CN Shares Outstanding by year
PeriodShares Outstanding
2026151.9M
2025129.54M
2024115.83M
202390.1M
202285.22M
202154.58M
202017.16M
20199.66M
20188.62M
20177.56M
Book Value Per Share (CAD)
-0.4-0.200.20.42017201820192020202120222023202420252026
BETR.CN Book Value Per Share (CAD) by year
PeriodBook Value Per Share (CAD)
2026-0.04
2025-0.06
2024-0.07
2023-0.08
2022-0.05
2021-0.08
20200.15
20190.36
2018-0.01
2017-0.26
Total Assets (CAD)
02.5M5M7.5M10M2017201820192020202120222023202420252026
BETR.CN Total Assets (CAD) by year
PeriodTotal Assets (CAD)
2026219.9K
2025224.96K
2024324.75K
202374.73K
20221.16M
20211.34M
20208.25M
20198.6M
2018473.52K
2017173.84K
Free Cash Flow Yield
-25%-20%-15%-10%-5%0%med -10.64%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
BETR.CN Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-1.62%
Sep 26-1.84%
Aug 26-1.75%
Aug 26-1.69%
Aug 26-1.93%
Aug 26-1.3%
Jul 26-1.9%
Jul 26-1.96%
Jul 26-1.92%
Jul 26-2.11%
Jul 26-2.17%
Jun 26-2.75%
Jun 26-6.33%
Jun 26-5.88%
Jun 26-6.86%
May 26-6.86%
May 26-6.86%
May 26-6.86%
May 26-6.33%
May 26-6.33%
Apr 26-2.39%
Apr 26-2.39%
Apr 26-2.2%
Apr 26-2.2%
Mar 26-2.39%
Mar 26-2.05%
Mar 26-2.05%
Mar 26-1.69%
Feb 26-2.39%
Feb 26-2.61%
Feb 26-2.61%
Feb 26-2.39%
Jan 26-2.87%
Jan 26-4.65%
Jan 26-5.16%
Jan 26-4.65%
Jan 26-5.16%
Dec 25-5.16%
Dec 25-4.65%
Dec 25-4.65%
Dec 25-4.22%
Nov 25-4.22%
Nov 25-4.65%
Nov 25-3.87%
Nov 25-3.87%
Oct 25-3.57%
Oct 25-15.08%
Oct 25-13.92%
Oct 25-13.92%
Oct 25-12.92%
Sep 25-12.06%
Sep 25-10.64%
Sep 25-10.64%
Sep 25-10.64%
Aug 25-10.64%
Aug 25-10.64%
Aug 25-10.64%
Aug 25-10.05%
Aug 25-9.52%
Jul 25-15.61%
Jul 25-16.43%
Jul 25-16.43%
Jul 25-17.34%
Jun 25-15.61%
Jun 25-15.61%
Jun 25-17.34%
Jun 25-18.36%
May 25-16.43%
May 25-15.61%
May 25-14.19%
May 25-18.36%
May 25-17.34%
Apr 25-17.44%
Apr 25-19.38%
Apr 25-20.52%
Apr 25-20.52%
Mar 25-19.38%
Mar 25-20.52%
Mar 25-18.36%
Mar 25-18.36%
Feb 25-17.44%
Feb 25-15.85%
Feb 25-15.16%
Feb 25-16.61%
Jan 25-13.41%
Jan 25-14.89%
Jan 25-18.13%
Jan 25-18.13%
Jan 25-18.96%
Dec 24-19.86%
Dec 24-19.86%
Dec 24-18.96%
Dec 24-18.96%
Nov 24-16.68%
Nov 24-19.86%
Nov 24-18.13%
Nov 24-18.13%
Nov 24-17.38%
Oct 24-14.83%
Oct 24-14.83%
Price to Sales
0200400600800med 343.65Feb 20Apr 20Jun 20Aug 20Oct 20Nov 20Jan 21
BETR.CN Price to Sales by year
PeriodPrice to Sales
Jan 21407.74
Jan 21376.19
Jan 21405.31
Dec 20487.83
Dec 20398.03
Dec 20303.38
Dec 20220.86
Dec 20223.29
Nov 20167.46
Nov 20138.34
Nov 20145.62
Nov 20143.19
Oct 20152.9
Oct 20198.85
Oct 20244.92
Oct 20266.75
Oct 20257.05
Sep 20254.62
Sep 20252.2
Sep 20363.75
Sep 20361.32
Aug 20594.12
Aug 20594.12
Aug 20594.12
Aug 20594.12
Jul 20594.12
Jul 20626.24
Jul 20456.99
Jul 20459.4
Jul 20505.35
Jun 20420.72
Jun 20471.49
Jun 20435.23
Jun 20423.14
May 20483.58
May 20507.76
May 20544.03
May 20580.3
May 20362.69
Apr 20349.68
Apr 20241.16
Apr 20168.81
Apr 20180.87
Mar 20168.81
Mar 20156.75
Mar 20229.1
Mar 20241.16
Feb 20168.81
Feb 20241.16
Feb 20337.62
Feb 20301.45
Jan 20325.56
EV/EBITDA
140160180200220med 164.86Oct 25Nov 25Nov 25Dec 25Dec 25Jan 26Jan 26
BETR.CN EV/EBITDA by year
PeriodEV/EBITDA
Jan 26164.86
Jan 26149.63
Jan 26164.86
Jan 26149.63
Dec 25149.63
Dec 25164.86
Dec 25164.86
Dec 25180.08
Nov 25180.08
Nov 25164.86
Nov 25195.3
Nov 25195.3
Oct 25210.52
Price to Book
0510152025med 9.41Nov 19Feb 20Jun 20Sep 20Jan 21Apr 21Jan 22
BETR.CN Price to Book by year
PeriodPrice to Book
Jan 2212.7
Jan 2213.61
Jan 2213.91
Jan 2213.91
Dec 2113.01
Dec 2114.82
Dec 2112.4
Dec 2113.31
Dec 2114.82
Nov 2116.94
Nov 2118.45
Nov 2116.33
Nov 2116.94
Oct 2116.94
Apr 218.33
Apr 218.33
Apr 219.94
Apr 2112.3
Apr 2115.53
Mar 2116.16
Mar 2117.15
Mar 2117.4
Mar 2117.52
Feb 2117.65
Feb 2120.38
Feb 2117.15
Feb 2117.65
Jan 2116.9
Jan 2112.26
Jan 2111.31
Jan 2112.19
Dec 2014.67
Dec 2011.97
Dec 209.12
Dec 206.64
Dec 206.72
Nov 205.04
Nov 204.16
Nov 204.38
Nov 204.31
Oct 204.6
Oct 204.74
Oct 205.84
Oct 206.36
Oct 206.13
Sep 206.07
Sep 206.02
Sep 208.68
Sep 208.62
Aug 2014.17
Aug 2014.17
Aug 2014.17
Aug 2014.17
Jul 2014.17
Jul 2016.73
Jul 2012.21
Jul 2012.27
Jul 2013.5
Jun 2011.24
Jun 2012.6
Jun 2011.63
Jun 2011.3
May 2012.92
May 2013.56
May 2014.53
May 2015.5
May 209.69
Apr 201.7
Apr 201.18
Apr 200.82
Apr 200.88
Mar 200.82
Mar 200.76
Mar 201.12
Mar 201.18
Feb 200.82
Feb 201.18
Feb 201.65
Feb 201.47
Jan 201.59
Jan 201.14
Jan 201.24
Jan 201.24
Jan 201.29
Dec 191.33
Dec 191.19
Dec 191.52
Dec 191.43
Nov 191.33
Nov 191.19
Nov 191.24
Nov 191.19
Nov 191.43
Oct 193.69
Oct 194.43
Oct 195.61
Oct 197.09
Sep 197.68
Sep 198.57
Sep 1910.34
BetterLife Pharma Inc.
BETR.CN
Stockpicker

Video analysis: BETR.CN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BETR.CN

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.